Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Oct 14, 2021

SELL
$68.67 - $84.02 $1.43 Million - $1.75 Million
-20,879 Closed
0 $0
Q2 2021

Jul 19, 2021

SELL
$79.87 - $87.53 $38.3 Million - $41.9 Million
-479,102 Reduced 95.82%
20,879 $1.76 Million
Q1 2021

Apr 28, 2021

BUY
$76.02 - $100.5 $2.16 Million - $2.86 Million
28,458 Added 6.04%
499,981 $40.6 Million
Q4 2020

Jan 20, 2021

SELL
$80.74 - $97.7 $160,349 - $194,032
-1,986 Reduced 0.42%
471,523 $41 Million
Q3 2020

Oct 29, 2020

BUY
$85.07 - $109.69 $305,486 - $393,896
3,591 Added 0.76%
473,509 $42.5 Million
Q2 2020

Jul 10, 2020

SELL
$74.18 - $108.93 $2.66 Million - $3.91 Million
-35,870 Reduced 7.09%
469,918 $48.9 Million
Q1 2020

Apr 13, 2020

BUY
$63.18 - $85.97 $304,843 - $414,805
4,825 Added 0.96%
505,788 $37 Million
Q4 2019

Jan 10, 2020

SELL
$73.04 - $95.72 $1.78 Million - $2.33 Million
-24,368 Reduced 4.64%
500,963 $43.7 Million
Q3 2019

Oct 10, 2019

SELL
$72.82 - $86.52 $21.9 Million - $26.1 Million
-301,367 Reduced 36.45%
525,331 $39 Million
Q2 2019

Jul 24, 2019

SELL
$73.52 - $88.7 $57 Million - $68.8 Million
-775,146 Reduced 48.39%
826,698 $70.2 Million
Q1 2019

Apr 10, 2019

SELL
$63.56 - $88.17 $45.9 Million - $63.7 Million
-722,429 Reduced 31.08%
1,601,844 $138 Million
Q4 2018

Jan 24, 2019

SELL
$58.5 - $69.94 $134 Million - $160 Million
-2,291,216 Reduced 49.64%
2,324,273 $148 Million
Q3 2018

Oct 10, 2018

BUY
$61.75 - $74.23 $20.4 Million - $24.6 Million
330,895 Added 7.72%
4,615,489 $319 Million
Q2 2018

Jul 13, 2018

BUY
$60.85 - $83.98 $147 Million - $202 Million
2,409,374 Added 128.48%
4,284,594 $287 Million
Q1 2018

May 01, 2018

BUY
$83.06 - $100.98 $59.5 Million - $72.4 Million
716,584 Added 61.85%
1,875,220 $156 Million
Q4 2017

Feb 05, 2018

BUY
$93.56 - $116.6 $108 Million - $135 Million
1,158,636
1,158,636 $110 Million

Others Institutions Holding INCY

About INCYTE CORP


  • Ticker INCY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 222,431,008
  • Market Cap $16B
  • Description
  • Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...
More about INCY
Track This Portfolio

Track Manning & Napier Group, LLC Portfolio

Follow Manning & Napier Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Manning & Napier Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Manning & Napier Group, LLC with notifications on news.